Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
activities of daily living
activities of daily living scale
adverse drug reaction
agitation
akathisia
alpha methyldopa hydrazine
Alzheimer's disease
amiodarone
amphotericin B
anticholinergic drugs
anticonvulsants
anticonvulsants, cognitive function with
anticonvulsants, untoward effects of
antidepressant
anxiolytic agents
asterixis
ataxia
ataxia, cerebellar
ataxia, truncal
ataxic gait
autonomic dysfunction
basal ganglia
basal ganglia, lesion of
benign essential tremor
bethanechol
bradykinesia
brain transplantation
burning paresthesia
buspirone
butyrophenone
calcium antagonist
calcium antagonist, side effects of
CAT scan
CAT scan, abnormal
CAT scan, contrast enhanced
CAT scan, emission
CAT scan, emission, abnormal
central nervous system, infection of
cerebrospinal fluid, MHPG(3-methoxy 4-hydroxyphenyl glycol)
cerebrovascular accident
cerebrovascular accident, acute management of
chemotherapy, CNS treatment and complications with
chlorpromazine
cholinergic drug
chorea
cinnarizine
clozapine
cognition
complications
contrast agents, neurotoxicity of
creatine phosphokinase(CPK)elevated
cyanide poison
dementia
depression
diltiazem
diplopia
diquat
disulfiram
dopamine antagonist
drug abuse
drug abuse, neurologic complications of
drug induced neurologic disorders
drug interactions
drug overdose
dyskinesia
dyskinesia, buccal lingual facial
dystonia
dystonia, drug induced
dystonic reaction, acute
ecstasy
emergencies, neurologic
emergency room
encephalopathy
enzyme inhibition
epidemiology of neurology
facial movement disorder
falling
fetal tissue
fever
flunarizine
fluorouracil
fluoxetine
fluvoxamine
GM1 ganglioside
haloperidol
headache
headache, treatment of
hemiballismus
hemichorea
herbicide
hexane
HMGcoA reductase inhibitors
huffing
human immunodeficiency virus type 1
Huntington's chorea
hyperthermia
iatrogenic neurologic disorders
inclusion bodies, eosinophilic cytoplasmic
intellectual deficit
L-dopa
L-dopa, potentiators of
lenticular nucleus, lesion of
lenticular nucleus, lesion of, bilateral
Lewy body
Lewy body disease, diffuse
lipid lowering agent
lithium
locus ceruleus, lesion of
lovastatin
manganese intoxication
medical-legal aspects of neurology
memory, impairment of
mental status, abnormal
meperidine
metoclopramide
migraine, prophylaxis
migraine, treatment of
misdiagnosis
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, treatment of
MPTP
MRI
MRI, abnormal
multiple system atrophy
myoclonus
naproxen
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neuropathology
neuropathology, brain
neuroprotective agents
neurotoxic
neurotoxin
nonsteroidal anti-inflammatory drug
nursing home
nystagmus
occupational neurologic disorders
octreotide
olanzapine
old age, neurology of
ophthalmoplegia
paresthesias
paresthesias, facial
Parkinson disease
Parkinson disease, arteriosclerotic
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, drug induced
Parkinson disease, exacerbation
Parkinson disease, misdiagnosis
Parkinson disease, progression
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinson disease, unmasked
Parkinsonism hyperpyrexia syndrome
Parkinsonism multiple-system atrophy
Parkinsonism syndrome
paroxetine
paroxysmal nonkinesigenic dyskinesia
phenothiazine
poison, neurologic problems with
prognosis
progressive supranuclear palsy
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
putamen, lesion of
putamen, lesion of, bilateral
quetiapine
Rabbit syndrome
renal failure
review article
rhabdomyolysis
rigidity
risperidone
seizure
seizure, treatment of
selective serotonin reuptake inhibitors
serotonin syndrome
sertraline
sinemet
single photon emission computed tomography
sodium valproate
sodium valproate, toxicity
solvent
stridor
subarachnoid hemorrhage
subarachnoid hemorrhage, treatment of
substantia nigra tissue
tardive dyskinesia
tardive dyskinesia, treatment of
tardive dystonia
tetrabenazine
tic
toxins, nervous system
transient neurologic deficit
treatment of neurologic disorder
tremor
tremor, jaw
tricyclic antidepressant
vasospasm, cerebral
verapamil
vision, blurred
wheelchair
Showing articles 800 to 850 of 1606 << Previous Next >>

Motor Neuron Disease with Parkinsonism
Arch Neurol 53:987-991, Qureshi,A.I.,et al, 1996

Precipitants of Brain Infarction:Roles of Preceding Infection/Inflammation & Recent Psychological Stress
Stroke 27:1999-2004, Macko,R.F.,et al, 1996

Startle Provoked Epileptic Seizures:Features in 19 Patients
JNNP 61:151-156, Manford,M.R.A.,et al, 1996

Treatment of Advanced Parkinson's Disease by Posterior GPi Pallidotomy:1-Year Results of a Pilot Study
Ann Neurol 40:355-366, 3411996., Baron,M.S.,et al, 1996

Delayed Emergence of a Park Dis in 38% of 29 Older Men Initially Dx with Idiop REM Sleep Behavior Disorder
Neurol 46:388-393, Schenck,C.H.,et al, 1996

A 60-Year-Old Man with Parkinson's Disease
JAMA 275:716-722, Olanow,C.W., 1996

Lewy Body Disease and Dementia
Arch Int Med 156:487-493, Kalra,S.,et al, 1996

Natural History of Progressive Supranuclear Palsy & Clin Predictors of Survival:A Clinicopath Study
JNNP 61:615-620, Litvan,I.,et al, 1996

Effect of Thalamic Stimulation on Gait in Parkinson Disease
Arch Neurol 53:898-903, Defebvre,L.,et al, 1996

Deep Brain Stimulation for Essential Tremor
Neurol 46:1150-1153, Hubble,J.P.,et al, 1996

Manganese Toxicity in Children Receiving Long-Term Parental Nutrition
Lancet 347:1218-1221, Fell,J.M.E.,et al, 1996

Frequency of Dementia in Parkinson Disease
Arch Neurol 42:428-431, Aarsland,D.,et al, 1996

Case-Control Study of Idiopathic Parkinson's Disease and Dietary Vitamin E Intake
Neurol 46:1270-1274, Morens,D.M.,et al, 1996

Multicenter, Placebo-Controlled Trial of Cabergoline Taken Once Daily in the Treatment of Parkinson's Disease
Neurol 46:1062-1065, Hutton,J.T.,et al, 1996

Survival & Prolif of Nonneural Tissu, with Obstr of Cereb Ventric, In Parkinson Pt Trt with Fetal Allografts
Neurol 46:1219-1225, Folkerth,R.D.&Durso,R., 1996

Diffuse Lewy Body Disease:Clinical Features in Nine Cases without Coexistent Alzheimer's Disease
JNNP 60:531-538, Hely,M.A.,et al, 1996

Double-Blind Comparison of Cabergoline & Bromocriptine in Parkinson's Disease Pts with Motor Fluctuations
Neurol 47:785-788, Inzelberg,R.,et al, 1996

Gamma Knife Pallidotomy in Advanced Parkinson's Disease
Ann Neurol 39:535-538, Friedman,J.H.,et al, 1996

Diet and Parkinson's Diseae I:A Possible Role for the Past Intake of Specific Foods and Food Groups
Neurol 47:636-643, Hellenbrand,W.,et al, 1996

Living with Parkinson's Disease
NEJM 334:114-116, Salzman,E.W., 1996

Prevalence of Parkinsonian Signs and Associated Mortality in a Community Population of Older People
NEJM 334:71-76, Bennett,D.A.,et al, 1996

Incorrect Diagnosis of Alzheimer's Disease:A Clinicopathologic Study
Arch Neurol 53:35-42, Klatka,L.A.,et al, 1996

Bent Spine Syndrome
JNNP 60:51-54, Serratrice,G.,et al, 1996

Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Subjects Not Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:29-361996., , 1996

Impact of Deprenyl and Toxopherol Treatment on Parkinson's Disease in DATATOP Patients Requiring Levodopa
Parkinson Study Group, Ann Neurol 39:37-451996., , 1996

Oral and Genital Pain Syndromes in Parkinson's Disease
Movement Disorders 11:421-426, Ford,B.,et al, 1996

Liquid Levodopa/Carbidopa Produces Significant Improvement in Motor Function without Dyskinesia Exacerbation
Neurol 47:1493-1495, Pappert,E.J.,et al, 1996

Status Epilepticus in Children with Epilepsy:The Role of Antiepileptic Drug Levels in Prevention
Pediatrics 98:1119-1121, Maytal,J.,et al, 1996

Visual Hallucinations Associated with Parkinson Disease
Arch Neurol 53:1265-1268, Sanchez-Ramos,J.R.,et al, 1996

Transient Hemiballism/Hemichorea Dur to an Ipsilateral Subthalamic Nucleus Infarction
Neurol 46:267-268, Crozier,S.,et al, 1996

Extrapyramidal Symptoms in a BMT Recipient with Hyperintense Basal Ganglia and Elevated Manganese
Bone Marrow Transplantation 15:989-992, Fredstrom,S.,et al, 1995

Magnetic Resonance Imaging of Brain Iron in Health and Disease
J Neurol Sci 134:19-26,1, Vymazal,J.,et al, 1995

Retroperitoneal Fibrosis in a Patient with Parkinson's Disease Treated with Pergolide
Clin NeuroPharmacol 18:277-279, Jimenez-Jimenez,F.J.,et al, 1995

The Effect of Deprenyl and Levodopa on the Progression of Parkinson's Disease
Ann Neurol 38:771-777, Olanow,C.W.,et al, 1995

Complementary Positron Emission Tomographic Studies of the Striatal Dopaminergic System in Parkinson's Disease
Arch Neurol 52:1183-1190, Antonini,A.,et al, 1995

MRI In Patients with Suspected Vascular Parkinsonism
Neurol 45:2183-2188, Jijlmans,J.C.M.,et al, 1995

Early Differential Diagnosis of Parkinson's Disease with F-flurodeoxyglucose and Positron Emission Tomography
Neurol 45:1995-2004, Eidelberg,D.,et al, 1995

Effect of GPi Pallidotomy on Motor Function in Parkinson's Disease
Lancet 346:1383-1387, Lozano,A.M.,et al, 1995

Clinical and[18F]dopa PET Findings in Early Parkinson's Disease
JNNP 59:597-600, Morrish,P.K.,et al, 1995

Generalized Mitochondrial Dysfunction in Parkinson's Disease Detected by Magnetic Resonance Spectroscopy of Muscle
Neurol 45:2097-2099, Penn,A.M.W.,et al, 1995

Decreased SPECT[123I]B-CIT Striatal Uptake Correlates with Symptom Severity in Parkinson's Disease
Ann Neurol 38:589-598, Seibyl,J.P.,et al, 1995

Neurological Sequelae of Cyanide Intoxication-The Patterns of Clinical MRI & Pet Findings
Ann Neurol 38:825-828, Rosenow,F.,et al, 1995

Comparison of Therapeutic Effects & Mortality Data of Levodopa & Levodopa with Selegiline in Pts with Early, Mild Parkinson's
BMJ 311:1602-1607, 15831995., Lee,A.J.,et al, 1995

Dopa-Responsive parkinsonism Phenotype of Machado-Jospeh Disease:Confirmation of 14q CAG Expansion
Ann Neurol 48:684-687, Tuite,P.J.,et al, 1995

Apolipoprotein E Genotype in Diverse Neurodegenerative Disorders
Ann Neurol 38:131-135, Schneider,J.A.,et al, 1995

Hemiballismus:CT and MR Findings
J Comput Assist Tomogr 19:537-540, Provenzale,J.M.&Glass,J.P., 1995

Psychogenic Parkinsonism
Arch Neurol 52:802-810, Lang,A.E.,et al, 1995

Reading-Induced Absence Seizures
Neurol 45:1623-1624, Singh,B.,et al, 1995

First Seizures Associated with Playing Electronic Screen Games:A Community-Based Study in Great Britain
Ann Neurol 37:733-737, Quirk,J.A.,et al, 1995

Encephalopathy with Parkinsonian Features in Children Following Bone Marrow Transplantations and High-Dose Amphotericin B
Ann Neurol 37:810-814, Mott,S.H.,et al, 1995



Showing articles 800 to 850 of 1606 << Previous Next >>